24 Mar 2016 13:21
24 March 2016
Sinclair Pharma plc
Notice of Results
LONDON, UK, 24 March, 2016 - Sinclair Pharma plc (AIM: SPH.L) ("Sinclair" or "the Group"), the international company operating in the fast growing global aesthetics market, will announce its interim results to 31 December 2015 on Wednesday 30 March 2016. A briefing for analysts will be held at 10.15 BST on 30 March at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD. A live audio webcast and slide presentation of this event will also be available at www.sinclairpharma.com.
-Ends-
For further information, please contact:
Sinclair Pharma plc Chris Spooner/Alan Olby | Tel: +44 (0) 20 7467 6920 |
Peel Hunt LLP James Steel/Oliver Jackson | Tel: +44 (0) 20 7418 8900 |
FTI Consulting Ben Atwell/Brett Pollard/Stephanie Cuthbert/Robert Winder | Tel: +44 (0) 20 3727 1000 |
About Sinclair Pharma plc - see www.sinclairpharma.com
Sinclair Pharma plc is an international company that operates in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. The group has an established sales and marketing presence in the leading EU markets' and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners.
Sinclair Pharma (SPH)